| Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19 E Villa, R Critelli, S Lasagni, A Melegari, A Curatolo, C Celsa, ... Blood advances 5 (3), 662-673, 2021 | 54 | 2021 |
| Hepatitis C: standard of treatment and what to do for global elimination L Di Marco, C La Mantia, V Di Marco Viruses 14 (3), 505, 2022 | 39 | 2022 |
| From undetectable equals untransmittable (U= U) to breastfeeding: is the jump short? T Prestileo, S Adriana, DM Lorenza, A Argo Infectious Disease Reports 14 (2), 220-227, 2022 | 27 | 2022 |
| Role of vitamin D in liver disease and complications of advanced chronic liver disease F Ravaioli, A Pivetti, L Di Marco, C Chrysanthi, G Frassanito, ... International Journal of Molecular Sciences 23 (16), 9016, 2022 | 26 | 2022 |
| Effectiveness of a screening program for HBV, HCV, and HIV infections in African migrants to Sicily T Prestileo, V Di Marco, O Dino, A Sanfilippo, M Tutone, M Milesi, ... Digestive and Liver Disease 54 (6), 800-804, 2022 | 17 | 2022 |
| Feasibility, safety, and outcome of second-line nivolumab/bevacizumab in liver transplant patients with recurrent hepatocellular carcinoma L Di Marco, A Pivetti, FG Foschi, R d’Amico, F Schepis, C Caporali, ... Liver Transplantation 29 (5), 559-563, 2023 | 16 | 2023 |
| RESIST-HCV criteria to monitor progression of low-risk esophageal varices in patients with compensated cirrhosis after HCV eradication: the SIMPLE study: SIMPLE: Scoring Index … V Calvaruso, C Celsa, R D'Ambrosio, F Simone, S Petta, I Cacciola, ... Official journal of the American College of Gastroenterology| ACG 117 (11 …, 2022 | 11 | 2022 |
| From listing to recovery: a review of nutritional status assessment and management in liver transplant patients F Ravaioli, N De Maria, L Di Marco, A Pivetti, R Casciola, C Ceraso, ... Nutrients 15 (12), 2778, 2023 | 8 | 2023 |
| Mer Tyrosine Kinase (MERTK) modulates liver fibrosis progression and hepatocellular carcinoma development RM Pipitone, V Calvaruso, L Di Marco, F Di Salvo, M Gaggianesi, G Lupo, ... Frontiers in Immunology 13, 926236, 2022 | 7 | 2022 |
| Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation S Lasagni, F Leonardi, A Pivetti, L Di Marco, F Ravaioli, M Serenari, ... Frontiers in Oncology 12, 960808, 2022 | 6 | 2022 |
| Upregulation of the oestrogen target gene SIX1 is associated with higher growth speed and decreased survival in HCV-positive women with hepatocellular carcinoma RM Critelli, F Milosa, A Romanzi, S Lasagni, G Marcelli, L Di Marco, ... Oncology letters 24 (5), 395, 2022 | 3 | 2022 |
| Impact of direct-acting antivirals (DAAs) on cardiovascular diseases in patients with chronic hepatitis C. G Pennisi, F Spatola, L Di Marco, V Di Martino, V Di Marco | 3 | 2021 |
| Long-Term SARS-CoV-2 Antibody Seroprevalence in Blood Donors, Italy M Ferrari, L Di Marco, A Pivetti, S Paduano, C Vecchi, V Bernabucci, ... Emerging Infectious Diseases 29 (7), 1479, 2023 | 2 | 2023 |
| Prognostic significance of hypoxic and metabolic gene profiling in hepatocellular carcinoma F Milosa, RM Critelli, S Lasagni, A Pivetti, L Di Marco, D Romagnoli, ... Liver Cancer International 2 (1), 15-26, 2021 | 2 | 2021 |
| Abstract PO003: Combination therapy with Nivolumab/Bevacizumab is safe and effective in patients with recurrent hepatocellular carcinoma after liver transplant L Di Marco, A Pivetti, N De Maria, FG Foschi, D Romagnoli, F Casari, ... Clinical Cancer Research 28 (17_Supplement), PO003-PO003, 2022 | 1 | 2022 |
| Safety and clinical activity of combination treatment with regorafenib and milciclib in liver transplant patients with hepatocellular carcinoma recurrence. A Pivetti, L Di Marco, L Bristot, F Milosa, RM Critelli, N De Maria, ... Journal of Clinical Oncology 38 (15_suppl), e16634-e16634, 2020 | 1 | 2020 |
| AA genotype of the deSNP rs6726639 of gene MERTK (MER Tyrosine Kinase) is associated with development of hepatocellular carcinoma after hepatitis C virus clearance V Calvaruso, S Grimaudo, S Petta, RM Pipitone, G Cabibbo, E Conte, ... Age (years, mean±SD) 66, 10.4, 2019 | 1 | 2019 |
| AA genotype of deSNP rs6726639 of MERTK gene is associated with development of Hepatocellular Carcinoma after eradication of Hepatitis C Virus infection L Di Marco, V Calvaruso, S Grimaudo, S Petta, MR Pipitone, G Cabibbo, ... Digestive and Liver Disease 51, e7, 2019 | 1 | 2019 |
| A Comprehensive Review of Antiviral Therapy for Hepatitis C: The Long Journey from Interferon to Pan-Genotypic Direct-Acting Antivirals (DAAs) L Di Marco, S Cannova, E Ferrigno, G Landro, R Nonni, CL Mantia, ... Viruses 17 (2), 163, 2025 | | 2025 |
| MANAGEMENT CLINICO E TERAPEUTICO, CARATTERISTICHE BIOLOGICE, NEI PAZIENTI CON RECIDIVA DI EPATOCARCINOMA DOPO TRAPIANTO DI FEGATO. L DI MARCO Università degli studi di Modena e Reggio Emilia, 2025 | | 2025 |
